Shilian Hu
- Topics
- Epigenetics and DNA Methylation (5 papers)Cancer-related gene regulation (4 papers)RNA modifications and cancer (4 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Shilian Hu
44 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 115
- Molecular Biology 443
- Oncology 205
- Immunology 202
- Epidemiology 130
- Cancer Research 128
Countries citing papers authored by Shilian Hu
This map shows the geographic impact of Shilian Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilian Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilian Hu more than expected).
Fields of papers citing papers by Shilian Hu
This network shows the impact of papers produced by Shilian Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilian Hu. The network helps show where Shilian Hu may publish in the future.
Co-authorship network of co-authors of Shilian Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Shilian Hu. A scholar is included among the top collaborators of Shilian Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilian Hu. Shilian Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 10 | |
| 4 | 14 | |
| 5 | 11 | |
| 6 | 65 | |
| 7 | Method for quantitative determination of matrine in Sophora alopecuroidesL. and its inhibitory effect on breast cancer MCF-7 cell proliferation. | 2 |
| 8 | 26 | |
| 9 | 129 | |
| 10 | 34 | |
| 11 | Genistein inhibits the proliferation of human HER2-positive cancer cells by downregulating HER2 receptor | 4 |
| 12 | 55 | |
| 13 | 6 | |
| 14 | [Effects of aging and decreased glomerular filtration rate on the prevalence of anemia in elderly population receiving body check from urban area of Hefei, China.]. | 1 |
| 15 | 6 | |
| 16 | 20 | |
| 17 | Systematic review of the effects of hyperbaric oxygen adjunctive therapy on brain injury. | 1 |
| 18 | 30 | |
| 19 | 91 | |
| 20 | 27 |
About Shilian Hu
Shilian Hu is a scholar working on Neuropsychology and Physiological Psychology, Biochemistry and Endocrine and Autonomic Systems, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Endocrine and Autonomic Systems (70 citations), Immunology (202 citations) and Cancer Research (128 citations). Shilian Hu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Gan Shen, Min Cheng, Guodong Shen, Weiping Xu, Dabing Huang, Tingjuan Xu, Shi Yin, Xiaodong Jiang, Liting Qian and Xiang Fang. Their work appears in journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.